Table 3. Distribution of 173a patients according to tumour HIF-1α staining pattern.
Pattern of HIF-1α staining
|
||||
---|---|---|---|---|
Factor | HIF-1α focal positivity | HIF-1α negative | HIF-1α at the invasive edge | P * |
Differentiation | ||||
Well | 4 | 12 | 2 | |
Mod | 20 | 33 | 14 | |
Poor | 25 | 38 | 25 | 0.37 |
Lauren type | ||||
Diffuse | 24 | 41 | 23 | |
Intestinal | 25 | 42 | 18 | 0.74 |
T Stage | ||||
T in situ | 1 | 2 | 0 | |
T1 | 7 | 6 | 3 | |
T2 | 18 | 29 | 6 | |
T3 | 22 | 43 | 32 | |
T4 | 1 | 3 | 0 | 0.087 |
N Stage | ||||
N0 | 22 | 23 | 5 | |
N1 | 20 | 51 | 28 | |
N2 | 6 | 7 | 7 | |
N3 | 1 | 2 | 1 | 0.034 |
M stage | ||||
M0 | 48 | 81 | 40 | |
M1 | 1 | 2 | 1 | 0.99 |
Overall TNM stage | ||||
0 | 1 | 2 | 0 | |
I | 16 | 11 | 3 | |
II | 13 | 33 | 7 | |
III | 17 | 31 | 30 | |
IV | 2 | 6 | 6 | 0.001 |
Abbreviations: HIF=hypoxia inducible factor; TNM=tumour node metastasis.
Three patients with diffusely positive HIF-1α staining and one patient with a missing slide were excluded.
χ2 P-value.